Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt
06 Diciembre 2023 - 2:00AM
Business Wire
Share of 127-megawatt aggregated deal in
collaboration with Eurofins Scientific will power over half of
Thermo Fisher’s addressable European footprint with 100% renewable
electricity by 2025
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in
serving science, today announced a 15-year virtual power purchasing
agreement (VPPA) with international solar developer ib vogt. Thermo
Fisher’s 91-megawatt portion of the Serbal solar project will
deliver approximately 192,000 megawatt hours of renewable
electricity annually. Eurofins Scientific, a global leader in
bioanalytical testing, collaborated in the aggregated deal for a
36-megawatt portion of the project.
The project is expected to be operational in January 2025.
Thermo Fisher’s share will match over half of the company’s
addressable European sites with 100% renewable electricity, and the
aggregated share will simultaneously reduce both Thermo Fisher’s
and Eurofins’ respective Scope 2 and Scope 3 emissions.
“The participation of Eurofins in the Serbal solar project,
which boasts a capacity of 36 megawatts, creating approximately
76,000 megawatt hours of renewable electricity annually, represents
an important milestone on our path to Carbon Neutrality by 2025. It
helps us to significantly reduce carbon emissions across the
Eurofins network, ensuring that more than one-third of our
addressable European footprint is powered by 100% renewable
electricity,” said Dr. Gilles G. Martin, chief executive officer,
Eurofins Scientific. “We have taken a novel, value-chain-based
approach in working with Thermo Fisher Scientific, as a supplier
and partner, to reduce our Scope 2 emissions caused by electricity
consumption. We look forward to this collaboration with Thermo
Fisher, as we strive to contribute to global climate goals.”
To further accelerate its climate progress, Thermo Fisher has
established a commitment to achieve 80% renewable electricity
globally by 2030, in alignment with the Sustainable Markets
Initiative (SMI) Health Systems Task Force joint supplier
standards. This follows the company’s recently raised commitment to
reduce Scope 1 and 2 emissions by 50% by 2030 against a 2018
baseline, as well as its plans to power all of the company’s U.S.
sites with 100% renewable electricity by 2026 as it works to reach
net-zero emissions by 2050.
“This new global climate goal not only strengthens our record of
accelerated progress toward net-zero emissions, but it also
underscores our collaborative approach on this journey,” said Marc
N. Casper, chairman, president and chief executive officer, Thermo
Fisher Scientific. “By working together with customers who share
our vision for a healthier planet, we can achieve even greater
impact across our collective value chains. We thank Eurofins for
partnering with us on this meaningful action and ib vogt for the
opportunity to expand our virtual power purchasing efforts beyond
the US.”
“Renewable electricity offers a tangible way for global
companies to reduce their emissions,” said Anton Milner, chief
executive officer, ib vogt. “We want to thank Thermo Fisher and
Eurofins for selecting this site and for taking an approach that
will power their sustainability goals and move the life sciences
industry to the next chapter in the energy transition to net
zero.”
Sustainability Roundtable Inc. advised Thermo Fisher and
Eurofins on this VPPA. More information about Thermo Fisher’s
environmental, social, and governance progress can be found at
www.thermofisher.com/csr.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue of approximately $40 billion. Our
Mission is to enable our customers to make the world healthier,
cleaner and safer. Whether our customers are accelerating life
sciences research, solving complex analytical challenges,
increasing productivity in their laboratories, improving patient
health through diagnostics or the development and manufacture of
life-changing therapies, we are here to support them. Our global
team delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services,
Patheon and PPD. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231206224419/en/
Media Contact: Sandy Pound Phone: 781-622-1223 E-mail:
sandy.pound@thermofisher.com
Investor Contact: Rafael Tejada Phone: 781-622-1356 E-mail:
rafael.tejada@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Thermo Fisher Scientific (NYSE:TMO)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024